XML 35 R25.htm IDEA: XBRL DOCUMENT
v3.25.3

Segment Reporting (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
Schedule of Reconciliation of Profit or Loss | Segment revenue and net loss, including significant segment expenses regularly provided to the CODM are as follows (in thousands):
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2025 |  | 2024 |  | 2025 |  | 2024
Revenue |  | $ | 17,244 |  |  | $ | 12,507 |  |  | $ | 49,944 |  |  | $ | 41,986 |
Cost of revenue |  | 7,169 |  |  | 5,526 |  |  | 20,351 |  |  | 17,351 |
Gross profit |  | 10,075 |  |  | 6,981 |  |  | 29,593 |  |  | 24,635 |
Segment operating expenses: |  |  |  |  |  |  |  |
Employee expense |  | 8,418 |  |  | 7,007 |  |  | 23,501 |  |  | 20,422 |
Outside services |  | 1,103 |  |  | 992 |  |  | 3,567 |  |  | 3,181 |
Facilities related |  | 921 |  |  | 859 |  |  | 2,739 |  |  | 2,824 |
Travel & entertainment |  | 724 |  |  | 693 |  |  | 2,175 |  |  | 1,813 |
Stock compensation |  | 535 |  |  | 170 |  |  | 1,280 |  |  | 1,227 |
Depreciation and amortization |  | 281 |  |  | 256 |  |  | 810 |  |  | 787 |
Other 1 |  | 1,193 |  |  | 1,667 |  |  | 4,616 |  |  | 4,634 |
Total segment operating expenses |  | 13,175 |  |  | 11,644 |  |  | 38,688 |  |  | 34,888 |
Loss from operations |  | (3,100) |  |  | (4,663) |  |  | (9,095) |  |  | (10,253) |
Interest expense |  | (1,319) |  |  | (562) |  |  | (2,988) |  |  | (1,671) |
Loss on extinguishment of debt |  | — |  |  | — |  |  | (295) |  |  | — |
Change in fair value of warrant liability |  | (2,670) |  |  | — |  |  | (3,108) |  |  | — |
Interest income |  | 3 |  |  | 197 |  |  | 246 |  |  | 570 |
Loss before income taxes |  | (7,086) |  |  | (5,028) |  |  | (15,240) |  |  | (11,354) |
Income tax expense |  | (1) |  |  | — |  |  | (38) |  |  | — |
Segment net loss |  | $ | (7,087) |  |  | $ | (5,028) |  |  | $ | (15,278) |  |  | $ | (11,354) |
1 Other segment items included in Segment net loss include insurance expenses, trade show and conference expenses, fulfillment expenses, board compensation, clinical trial expenses, collaboration expenses and bank fees, among others.

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration